Cargando…
Targeting the p53 Pathway in Ewing Sarcoma
The p53 tumour suppressor plays a pivotal role in the prevention of oncogenic transformation. Cancers frequently evade the potent antitumour surveillance mechanisms of p53 through mutation of the TP53 gene, with approximately 50% of all human malignancies expressing dysfunctional, mutated p53 protei...
Autores principales: | Neilsen, Paul M., Pishas, Kathleen I., Callen, David F., Thomas, David M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005944/ https://www.ncbi.nlm.nih.gov/pubmed/21197471 http://dx.doi.org/10.1155/2011/746939 |
Ejemplares similares
-
XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2015) -
Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2015) -
Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016) -
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016) -
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
por: Pishas, Kathleen I., et al.
Publicado: (2018)